Success Metrics

Clinical Success Rate
88.0%

Based on 110 completed trials

Completion Rate
88%(110/125)
Active Trials
22(12%)
Results Posted
48%(53 trials)
Terminated
15(8%)

Phase Distribution

Ph phase_4
53
28%
Ph phase_1
13
7%
Ph phase_2
49
26%
Ph early_phase_1
4
2%
Ph phase_3
29
15%
Ph not_applicable
36
19%

Phase Distribution

17

Early Stage

49

Mid Stage

82

Late Stage

Phase Distribution184 total trials
Early Phase 1First-in-human
4(2.2%)
Phase 1Safety & dosage
13(7.1%)
Phase 2Efficacy & side effects
49(26.6%)
Phase 3Large-scale testing
29(15.8%)
Phase 4Post-market surveillance
53(28.8%)
N/ANon-phased studies
36(19.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.5%

110 of 135 finished

Non-Completion Rate

18.5%

25 ended early

Currently Active

22

trials recruiting

Total Trials

191

all time

Status Distribution
Active(30)
Completed(110)
Terminated(25)
Other(26)

Detailed Status

Completed110
unknown26
Recruiting15
Terminated15
Withdrawn10
Active, not recruiting7

Development Timeline

Analytics

Development Status

Total Trials
191
Active
22
Success Rate
88.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 14 (2.2%)
Phase 113 (7.1%)
Phase 249 (26.6%)
Phase 329 (15.8%)
Phase 453 (28.8%)
N/A36 (19.6%)

Trials by Status

unknown2614%
active_not_recruiting74%
recruiting158%
withdrawn105%
enrolling_by_invitation11%
completed11058%
not_yet_recruiting74%
terminated158%

Recent Activity

Clinical Trials (191)

Showing 20 of 191 trialsScroll for more
NCT06120140Phase 2

Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib

Active Not Recruiting
NCT03511118

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Recruiting
NCT01631617Phase 2

Effects of Treatments on Atopic Dermatitis

Recruiting
NCT00353158Phase 1

A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity

Completed
NCT07704957Phase 4

A Randomized Controlled Trial of Doxycycline Post Exposure Prophylaxis to Prevent Incident Bacterial STIs Among Women in the United States

Not Yet Recruiting
NCT07498010Phase 2

Doxycycline Use in Post-Operative Seromas

Recruiting
NCT04297592Phase 4

Antibiotic Prophylaxis in High-Risk Arthroplasty Patients

Enrolling By Invitation
NCT07164131Phase 4

Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams

Recruiting
NCT05445479

Retrospective Study for Identificatiopn of a Link Between Doxycycline and COVID-19 Treatment

Withdrawn
NCT05473520Phase 3

Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis

Recruiting
NCT04108897Early Phase 1

Analysis of the Microbiome in Rosacea

Active Not Recruiting
NCT07629167Phase 2

Isotretinoin vs. Doxycycline for Acneiform Rash in Patients Receiving Drugs That Target the MAPK Pathway

Not Yet Recruiting
NCT01917721Phase 2

Doxycycline Treatment to Prevent Progressive Coronary Artery Dilation in Children With Kawasaki Disease

Active Not Recruiting
NCT03532464Phase 4

Azithromycin Compared With Doxycycline for Treating Anorectal Chlamydia Trachomatis Infection Concomitant to a Vaginal Infection

Completed
NCT06446245Phase 2

Adjunctive Doxycycline for Central Nervous System Tuberculosis

Recruiting
NCT04310930Phase 2

Finding the Optimal Regimen for Mycobacterium Abscessus Treatment

Recruiting
NCT06545656Phase 4

Daily Doxycycline to Inform Sexually Transmitted Infection Prophylaxis Regimens

Completed
NCT01820910Phase 2

Phase II Trial of First-line Doxycycline for Ocular Adnexal Marginal Zone Lymphoma Treatment

Completed
NCT07544251Phase 4

Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne.

Recruiting
NCT02874430Phase 2

Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer

Terminated

Drug Details

Intervention Type
DRUG
Total Trials
191